サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1650817

バイオ医薬品バイオセパレーションシステムの世界市場

Biopharmaceutical Bioseparation Systems

出版日
ページ情報
英文 360 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.41円
バイオ医薬品バイオセパレーションシステムの世界市場
出版日: 2025年02月06日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 360 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

バイオ医薬品バイオセパレーションシステムの世界市場は2030年までに326億米ドルに到達

2024年に175億米ドルと推定されるバイオ医薬品バイオセパレーションシステムの世界市場は、2024年から2030年にかけてCAGR 10.9%で成長し、2030年には326億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるクロマトグラフィー技術は、CAGR 10.2%を記録し、分析期間終了時には158億米ドルに達すると予測されます。その他の技術セグメントの成長率は、分析期間中CAGR11.5％と推定されます。

米国市場は73億米ドルと推定、中国はCAGR13.3％で成長予測

米国のバイオ医薬品バイオセパレーションシステム市場は、2024年に73億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに39億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは13.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ9.0％と9.3％と予測されています。欧州では、ドイツがCAGR 9.8%で成長すると予測されています。

世界のバイオ医薬品バイオセパレーションシステム市場- 主要動向と促進要因まとめ

バイオ医薬品バイオセパレーションシステムは、治療用タンパク質、モノクローナル抗体、ワクチンなどを含むバイオ医薬品の生産と精製に不可欠なコンポーネントです。これらのシステムは、複雑な混合物から生体分子を分離・精製するために、クロマトグラフィー、ろ過、遠心分離などの様々な技術を採用しています。バイオ医薬品の需要は、慢性疾患や希少疾患の治療に有効であることから増加しており、効率的で信頼性の高いバイオ分離システムの必要性が高まっています。これらのシステムは、厳しい規制要件の対象となるバイオ医薬品の純度、力価、安全性を確保するために不可欠です。バイオセパレーション技術の進歩は、バイオ医薬品製造プロセスの効率と拡張性を高めています。

バイオ医薬品バイオセパレーション市場は、バイオ医薬品産業の拡大と高度なバイオセパレーション技術の採用増加により、大きな成長を遂げています。慢性疾患の蔓延、人口の高齢化、個別化医療に対する需要の高まりが、バイオ医薬品の生産に拍車をかけています。さらに、遺伝子治療や細胞治療のような新しい治療法の開発は、バイオセパレーション技術に新たな課題と機会をもたらしています。シングルユースシステムや連続処理の使用など、材料や方法における革新は、バイオセパレーションプロセスの効率と費用対効果を向上させています。このような進歩により、より大規模で高品質なバイオ医薬品の生産が可能になりつつあります。

バイオ医薬品バイオセパレーションシステム市場の成長は、いくつかの要因によって牽引されています。第一に、慢性疾患の蔓延と高齢化によってバイオ医薬品に対する需要が増加しており、効率的なバイオセパレーション・システムに対するニーズが高まっています。第二に、シングルユースシステムや連続処理などのバイオセパレーション技術の進歩が、バイオ医薬品製造の拡張性と費用対効果を高めています。第三に、遺伝子治療や細胞治療のような新しい治療法の開発は、バイオセパレーションに新たな課題と機会を生み出し、この分野の技術革新を促進しています。最後に、バイオ医薬品に対する厳しい規制要件が、製品の品質と安全性を確保するために高度なバイオセパレーション・システムの使用を必要としています。これらの要因が総合的にバイオ医薬品バイオセパレーションシステム市場の力強い成長に寄与しています。

セグメント

テクノロジー（クロマトグラフィー、その他のテクノロジー）

調査対象企業の例（全61件）

  • 3M Company
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Alfa Laval AB
  • GEA Group AG
  • AMS Biotechnology（Europe）Ltd.（amsbio）
  • Biotage AB
  • AnteoTech
  • BIA Separations d.o.o.
  • Heinkel Drying and Separation Group
  • 3B Pharmaceuticals GmbH
  • Critical Process Filtration, Inc.
  • Flottweg SE
  • Ellutia
  • Global Life Sciences Solutions USA LLC（Cytiva）

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-7973

Global Biopharmaceutical Bioseparation Systems Market to Reach US$32.6 Billion by 2030

The global market for Biopharmaceutical Bioseparation Systems estimated at US$17.5 Billion in the year 2024, is expected to reach US$32.6 Billion by 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Chromatography Technology, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$15.8 Billion by the end of the analysis period. Growth in the Other Technologies segment is estimated at 11.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.3 Billion While China is Forecast to Grow at 13.3% CAGR

The Biopharmaceutical Bioseparation Systems market in the U.S. is estimated at US$7.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2030 trailing a CAGR of 13.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.0% and 9.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.

Global Biopharmaceutical Bioseparation Systems Market - Key Trends & Drivers Summarized

Biopharmaceutical bioseparation systems are critical components in the production and purification of biopharmaceuticals, which include therapeutic proteins, monoclonal antibodies, and vaccines. These systems employ various techniques such as chromatography, filtration, and centrifugation to separate and purify biological molecules from complex mixtures. The demand for biopharmaceuticals is increasing due to their effectiveness in treating chronic and rare diseases, driving the need for efficient and reliable bioseparation systems. These systems are essential for ensuring the purity, potency, and safety of biopharmaceutical products, which are subject to stringent regulatory requirements. Advances in bioseparation technologies are enhancing the efficiency and scalability of biopharmaceutical manufacturing processes.

The biopharmaceutical bioseparation market is experiencing significant growth due to the expanding biopharmaceutical industry and the increasing adoption of advanced bioseparation techniques. The rise in the prevalence of chronic diseases, the aging population, and the growing demand for personalized medicine are fueling the production of biopharmaceuticals. Additionally, the development of novel therapies such as gene and cell therapies is creating new challenges and opportunities for bioseparation technologies. Innovations in materials and methods, such as the use of single-use systems and continuous processing, are improving the efficiency and cost-effectiveness of bioseparation processes. These advancements are enabling the production of high-quality biopharmaceuticals at larger scales.

The growth in the biopharmaceutical bioseparation systems market is driven by several factors. Firstly, the increasing demand for biopharmaceuticals, driven by the prevalence of chronic diseases and the aging population, is boosting the need for efficient bioseparation systems. Secondly, advancements in bioseparation technologies, including single-use systems and continuous processing, are enhancing the scalability and cost-effectiveness of biopharmaceutical manufacturing. Thirdly, the development of novel therapies such as gene and cell therapies is creating new challenges and opportunities for bioseparation, driving innovation in this field. Lastly, stringent regulatory requirements for biopharmaceutical products are necessitating the use of advanced bioseparation systems to ensure product quality and safety. These factors collectively contribute to the robust growth of the biopharmaceutical bioseparation systems market.

SCOPE OF STUDY:

The report analyzes the Biopharmaceutical Bioseparation Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Chromatography, Other Technologies)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 61 Featured) -

  • 3M Company
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Alfa Laval AB
  • GEA Group AG
  • AMS Biotechnology (Europe) Ltd. (amsbio)
  • Biotage AB
  • AnteoTech
  • BIA Separations d.o.o.
  • Heinkel Drying and Separation Group
  • 3B Pharmaceuticals GmbH
  • Critical Process Filtration, Inc.
  • Flottweg SE
  • Ellutia
  • Global Life Sciences Solutions USA LLC (Cytiva)

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of COVID-19 on Biopharmaceutical Bioseparation Market
    • Scope of Affinity Chromatography in Aiding the Vaccine Purification methodology
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Biopharmaceutical Bioseparation Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • A Prelude to Biopharmaceutical Bioseparation Systems
    • A Peek into Biopharmaceutical Manufacturing
    • Downstream Processing of Biosynthetic Products - An Overview
    • Bioseparation Systems - Invaluable Tools in Biopharmaceutical Manufacturing
    • US Remains Market Leader; Developing Countries to Drive Market Growth
    • Chromatography Leads the Pack
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Biopharmaceutical Market Drives Demand for Bioseparation Systems
    • Top 10 Biopharmaceutical Companies: 2023
    • Biological License Application (BLA) Approvals - 2023
    • Targeted Therapies Gain Momentum, Cancer Immunotherapies on the Rise
    • Process Intensification Aids in Greater Productivity
    • Evolution of Chromatography Applications for the Biopharmaceutical Sector
    • Chromatography in Cell & Gene Therapies
    • Chromatography Methods Fraught with Issues
    • Growing Biosimilars Market - A Clear Advantage for Bioseparation Technologies
    • Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe
    • Progressive Regulatory Framework Accelerates Product Approvals & Subsequently Market Revenues
    • Specific Guidelines for Biosimilars in Various Countries with Year of Publication
    • Biosimilars Regulatory Agencies in Select Regional Markets
    • Biosimilar Approvals in the US (2023)
    • Biosimilar Approvals in Europe (2023)
    • High Demand for Monoclonal Antibodies Generates Significant Opportunities for Bioseparation Systems
    • Downstream Processing - A Major Trend among Biopharmaceutical Manufacturers
    • Chromatography - The Gold Standard Separation Technology
    • Global Chromatography Market (2023): Percentage Share Breakdown of Value Sales by Chromatography Techniques for Gas Chromatography, Liquid Chromatography, Supercritical Fluid Chromatography, Thin Layer Chromatography, and Others
    • Increasing Demand for Gas Chromatography in Biopharma Separation
    • Superior Efficiency Drives Use of Synthetic Ligands in Affinity Chromatography
    • A Comparison of Protein and Synthetic Ligands
    • Pre-packed Disposable Columns in Chromatography Gain Attention
    • SMBC - An Old Approach Gaining Significant Attention
    • Major Advantages and Disadvantages of SMBC
    • Twin-Column SMB - An Emerging Alternative to Protein A Columns
    • Growing Focus on Alternatives to Protein A Chromatography
    • Chiral Chromatography Increases in Popularity
    • Chromatography Efficiency and Selectivity
    • Mixed-Mode Chromatography
    • Multimode Chromatography
    • Mixed-Mode and Multimode Media Offer Cost Savings
    • Flexible and Selective Chromatography Improves Biopharmaceutical Efficiencies
    • Inherent Benefits of Membrane Chromatography to Drive its Use in Bioprocessing
    • His-tagged purification of protein & Immobilized Metal Affinity Chromatography (IMAC)
    • Growing Use of Membrane Filtration in Biopharmaceutical Manufacturing
    • Downstream Production of Biopharmaceuticals: Filtration Challenges
    • Evolving Membrane Functions in Filtration for the Production of mAbs
    • Filtration Technology: The Future
    • Membrane Adsorbers Gain Ground in Biopharmaceutical Downstream Purification
    • Prospering Vaccine Market Drives Use of Ultrafiltration Techniques
    • Membrane & Bioseparation
    • Need for Highly Efficient Membranes Rises
    • Downstream Response of Industry to Upstream Scale-Up
    • Hand-powered Centrifuge setup can Diagnose Covid-19 for just a dollar a test
    • Cell Disruption & Methods Gain Popularity
    • Advent of Innovative Technologies Streamline and Enhance Production of Biopharmaceutical Systems
    • Affinity Technologies Improve Productivity
    • Nanofiber Chromatography Technology Advantageous
    • Convective Media Set to Gain Growing Use
    • Nanotechnology Set to Add Interesting Dimension to Biological Separation
    • Rise of Magnetic Nanoparticles
    • Magnetic Biological Separation: Key Steps
    • Why Carbon Nanotubes are Gaining Attention
    • Application of Nanoporous & Nanofiber Membranes
    • Key Challenges & the Road Ahead
    • Continuous Bioprocessing Holds Potential to Positively Impact Biomanufacturing
    • Perfusion Gains Attention
    • Use of Continuous Purification on the Rise in Viral Processes
    • Introduction of Integrated Continuous Bioprocessing System Improves Productivity and Minimizes Raw Material Wastage
    • Use of Continuous Processing Technique for Manufacturing Life-Saving Medicines Gains Momentum
    • Demand for Sustainable Nanofiber Chromatography Mechanism Witnesses an Upward Momentum
    • Use of Precipitation Technique for Purifying Therapeutic Proteins Exhibits a Surge
    • Continuous Bioseparation Gains Momentum
    • Single-Use Systems Play a Key Role
    • Minimizing Centrifugation Steps
    • Single-Use Disposable Technologies Gain Attention
    • Innovative Approaches to Overcome Perennial & Existing Challenges with Process Chromatography
    • Increase in Healthcare Spending Stirs Demand for Biopharmaceutical Bioseperation Systems
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Growing Preference for Personalized Medicine to Drive Market Growth
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biopharmaceutical Bioseparation Systems Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Chromatography by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Market Facts & Figures
    • Market Analytics
    • TABLE 11: USA Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: USA 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: Canada 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • JAPAN
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: Japan 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • CHINA
    • TABLE 20: China Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: China 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • EUROPE
    • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Europe 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • FRANCE
    • TABLE 29: France Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: France 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • GERMANY
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Germany 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Italy 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • TABLE 38: UK Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: UK 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Spain 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Russia 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Rest of Europe 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Asia-Pacific 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Australia 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • INDIA
    • TABLE 59: India Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: India 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: South Korea 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Latin America 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Argentina 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Brazil 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Mexico 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Latin America 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Middle East 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
  • AFRICA
    • TABLE 89: Africa Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Africa Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Africa 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030

IV. COMPETITION